L-35

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameL-35

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitorsTestosterone congeners inhibitors

TargetsTestosterone congenersSteroid 17-alpha-hydroxylase

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

ATC CodeN/A